prnewswire.comSoleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman7 days ago
benzinga.comSoleno Under Serious Scrutiny As Short Seller Alleges PWS Drug Is Overpriced, Unsafe12 days ago
benzinga.comAardvark's Hunger-Suppressing Drug Promises Weight Loss Without GI Distressabout 2 months ago
prnewswire.comLogiCare3PL Supports Commercial Launch of Soleno Therapeutics' VYKAT XR Following FDA Approval4 months ago
cnbc.comStocks making the biggest moves midday: General Motors, Petco, GameStop, Alibaba, Cava and more5 months ago
finance.yahoo.comSoleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment11 months ago
finance.yahoo.comSoleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome11 months ago
CashuSoleno Therapeutics Under Fire Over VYKAT™ XR Safety and Commercial Viability Concerns5 days ago
CashuSoleno Therapeutics Readies for Critical Earnings Report Amid Biotech Industry Developments19 days ago